TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

Clinical trial NCT05332496 · COMPLETED

Trial details

NCT number: NCT05332496
Sponsor: Zhongda Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2022-12-28
Primary completion: 2023-07-30
Enrollment: 941

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.